CVKD - Cadrenal Therapeutics Inc
8.28
0.285 3.442%
Share volume: 16,091
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$8.00
0.28
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-07-2024 | 11-07-2024 | 03-13-2025 | 05-08-2025 | 11-10-2025 | |
| Assets | |||||||
| Total Assets | 7.048 M | 5.457 M | 4.679 M | 10.124 M | 7.953 M | 4.088 M | |
| Current Assets | 7.028 M | 5.444 M | 4.672 M | 10.113 M | 7.945 M | 4.080 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 182.764 K | 171.384 K | 119.081 K | 14.445 K | 8.451 K | 90.838 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 6.566 M | 5.037 M | 4.364 M | 10.018 M | 7.336 M | 3.860 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.690 K | 1.220 K | 814.000 | 6.944 K | 4.678 K | 5.729 K | |
| Other Assets | 3.792 K | 12.447 K | 3.792 K | 3.792 K | 3.792 K | 2.167 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 7.048 M | 5.457 M | 4.679 M | 10.124 M | 7.953 M | 4.088 M | |
| Total liabilities | 856.315 K | 1.465 M | 1.267 M | 2.684 M | 1.840 M | 1.353 M | |
| Total current liabilities | 856.315 K | 1.465 M | 1.267 M | 2.684 M | 1.840 M | 1.353 M | |
| Accounts Payable | 400.373 K | 759.518 K | 496.823 K | 1.502 M | 1.278 M | 614.127 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 6.192 M | 3.992 M | 3.412 M | 7.440 M | 6.113 M | 2.735 M | |
| Common stock | 22.927 M | 23.120 M | 24.948 M | 33.162 M | 35.681 M | 38.656 M | |
| Retained earnings | -16.735 M | -19.128 M | -21.536 M | -25.723 M | -29.568 M | -35.921 M |